Randomised Controlled Trial of Foam Sclerotherapy Versus Ambulatory Phlebectomy for the Treatment of Varicose Vein Tributaries
Overview
- Phase
- Phase 4
- Intervention
- Ambulatory phlebectomy
- Conditions
- Varicose Veins
- Sponsor
- Imperial College London
- Enrollment
- 160
- Locations
- 1
- Primary Endpoint
- Re-intervention rate
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
This study will be comparing the treatment of varicose vein tributaries using either foam sclerotherapy or ambulatory phlebectomies. Patients will be randomised to having either ambulatory phlebectomy (group A) or foam sclerotherapy (group B) following treatment of their saphenous vein.
The re-intervention rates, safety, patient experience as well as the cost effectiveness of each intervention will be assessed.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults over 18 years of age
- •Symptomatic GSV or SSV vein reflux \> 0.5 seconds on colour Duplex
- •Varicose vein tributary requiring treatment
Exclusion Criteria
- •Current DVT
- •Recurrent varicose veins
- •Arterial disease (ABPI\<0.8)
- •Vein diameter \< 3mm
- •Preference for one of the treatment options
- •Patient who are unwilling to participate
- •Inability or unwillingness to complete questionnaires
- •Inability to attend follow-up appointments
- •Patient currently included in a study of varicose vein treatment
Arms & Interventions
Ambulatory Phlebectomy
Ambulatory phlebectomy of varicose vein tributaries
Intervention: Ambulatory phlebectomy
Foam Sclerotherapy
Injection of foam sclerosant into varicose vein tributaries
Intervention: Foam sclerotherapy
Outcomes
Primary Outcomes
Re-intervention rate
Time Frame: 12 months
Re-intervention on varicose vein tributaries during study period
Secondary Outcomes
- Generic quality of life score(12 months)
- Disease specific quality of life score(12 months)
- Disease-specific quality of life score(12 months)
- Degree of bruising at 2 weeks(2 weeks)
- Time to return to normal activities(2 weeks)
- Pain score over the first 10 days(2 weeks)
- Clinical score(12 months)